Table 3 Incidence of three main cancer types by blood group in the Golestan Cohort Study
From: Mortality and cancer in relation to ABO blood group phenotypes in the Golestan Cohort Study
Blood type | Gastric cancer | ESCC | Pancreatic cancer | |||
|---|---|---|---|---|---|---|
Number of cases | adjusted HR a (95% CI) | Number of cases | adjusted HR (95% CI) | Number of cases | adjusted HR (95% CI) | |
O | 39 | 1 | 69 | 1 | 20 | 1 |
A | 73 | 1.57 (1.06,2.32)* | 67 | 0.82 (0.58,1.15) | 21 | 0.91 (0.49,1.68) |
B | 58 | 1.59 (1.06,2.39)* | 62 | 0.94 (0.67,1.32) | 13 | 0.70 (0.35,1.42) |
AB | 18 | 1.35 (0.77,2.36) | 18 | 0.76 (0.45,1.27) | 5 | 0.75 (0.28,2.00) |
Non-O | 149 | 1.55 (1.09,2.21)** | 147 | 0.86 (0.64,1.14) | 39 | 0.81 (0.47,1.39) |
Rh+ | 170 | 1 | 206 | 1 | 53 | 1 |
Rh- | 18 | 1.57 (0.97,2.56) | 10 | 0.74 (0.39,1.39) | 6 | 1.70 (0.73,3.96) |